Trainee (Strengthening EU Biotech Act Preparedness via Modernisation of the CTIS Training Catalogue)
Job Description
About the traineeship programme
The Agency is looking for motivated, qualified recent graduates or students on an Erasmus+ or other programme or PhD students or Master's students (who posses a previous degree), who are interested in gaining experience and contribute to the Agency’s work for every patient in Europe. The purpose of a traineeship at the Agency is to perform tasks that are predominantly in the interest of the trainee’s training and principally serve to increase the trainee’s knowledge and to gain relevant experience.
Placement description
We are looking for a trainee in the Clinical Trial Transformation Office.
Specific objectives and projects
Learning outcomes
By the end of the traineeship, the trainee is expected to have developed:
- Solid understanding of the operations of the European Medicines Regulatory Network and its stakeholders;
- Solid understanding of how clinical trials are regulated and supervised at European Union level;
- Practical knowledge on the use and functioning of the Clinical Trials Information System (CTIS);
- Experience in reviewing, updating, and organising training and guidance materials;
- Skills in translating complex regulatory and technical information into clear, user-friendly content
- Improved written communication skills in a professional, multilingual European environment
- Basic project coordination and change management skills, including planning tasks, tracking progress, and working with deadlines
Eligibility criteria
To be eligible for consideration for this placement, you are required to:
- enjoy full rights as a citizen of a European Union Member State or Iceland, Lichtenstein and Norway;
- possess a university degree in pharmacy, medicine or biology (minimum of three years or more) that must have been obtained between 6 May 2025 and 6 May 2026 or be a university student on an Erasmus + or a similar programme or a PhD student or a Master's student with a previous fully finished degree in the areas mentioned before. Specialisation in clinical trials desirable.
- a thorough knowledge of English (at least level C1) and good knowledge of other official EU language (at least B2) of the Common European Framework for Languages
For criteria 1 and 2, you will be required to provide proof in the application form and at the interview stage. Failing to present these documents may result in the disqualification from the procedure.
Additional skills
Good written and oral communication skills.
Proficiency in AI, design and standard office software tools is desirable.
Behavioural Competencies
You will demonstrate the following behavioural competencies:
- Communication skills
- Interpersonal skills
- Working with others
- Adaptability
- Research and analytical skills
- Learning and development
Conditions of traineeship
The traineeship is offered for 10 months (1 October 2026 – 31 July 2027) and takes place at the Agency’s premises in Amsterdam with possibility for teleworking up to 40% of working time from The Netherlands and occasional teleworking from outside The Netherlands. Traineeships are offered for either full-time or part-time (80% or 50%) if combined with university studies.
The Agency pays a monthly stipend of €2,049.77 for a full-time traineeship (reduced accordingly for 80% or 50%) and a travel contribution upon joining the Agency.
Each trainee will have a mentor at the Agency who will guide the trainee through the programme.
The conditions of employment are stated in the Executive Decision on rules governing the traineeship programme at the EMA available here.
Expected selection timelines
| Deadline for applications | 06 May 2026 23:59 CET |
|---|---|
| Assessments (remote) | From mid-June 2026 to mid-July 2026 |
| Decision and offers | By end of July 2026 |
| Placement start | 1 October 2026 |